Jun Xiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jun Xiao has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Bin Zhu
Key Laboratory of Molecular Biophysics, the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China
4 shared publications - Longfei Wang
Department of Cardiology, Taikang Center for Life and Medical Sciences, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei 430074, China
4 shared publications - Rui Cheng
Key Laboratory of Molecular Biophysics, the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China
4 shared publications - Jing Li
Department of Chemical and Biomolecular Engineering, College of Chemistry, University of California, Berkeley, USA
3 shared publications - Lianrong Wang
Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China
2 shared publications Wuliu Yuan
Department of Cardiovascular Surgery, Zhongnan Hospital of, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China
2 shared publications
Latest Publications
- 21 May 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- p. eaef3178
DNA polymerization activates RNA cleavage of a reverse transcriptase–like antiviral enzyme
Defense-associated reverse transcriptases (DRTs) transcribe noncoding RNAs (ncRNAs) for antiviral defense, but the mechanisms of ncRNA-independent DRTs remain unclear. In this work, we show that a single DRT4 mediates RNA-targeting antiphage defense by integrating DNA polymerase, exonuclease, and RNA endonuclease activities. First, through an equilibrium between its DNA polymerase and exonuclease activities, DRT4 senses phage infection, as elevated dNTP levels shift the equilibrium toward polymerase activity, thereby promoting protein-primed single-stranded DNA (ssDNA) synthesis. Second, ssDNA of sufficient length, phage DNA-binding proteins, and deoxyguanosine triphosphate collectively activate an unusual RNA endonuclease activity of DRT4, excising 3′–guanosine monophosphate from both phage and host RNA to terminate infection. These findings reveal a distinctive immune strategy combining nucleic acid synthesis and degradation, expanding the functional landscape of DRTs for new DNA- and RNA-processing technologies.
- 21 May 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- p. eaef3178
DNA polymerization activates RNA cleavage of a reverse transcriptase–like antiviral enzyme
Defense-associated reverse transcriptases (DRTs) transcribe noncoding RNAs (ncRNAs) for antiviral defense, but the mechanisms of ncRNA-independent DRTs remain unclear. In this work, we show that a single DRT4 mediates RNA-targeting antiphage defense by integrating DNA polymerase, exonuclease, and RNA endonuclease activities. First, through an equilibrium between its DNA polymerase and exonuclease activities, DRT4 senses phage infection, as elevated dNTP levels shift the equilibrium toward polymerase activity, thereby promoting protein-primed single-stranded DNA (ssDNA) synthesis. Second, ssDNA of sufficient length, phage DNA-binding proteins, and deoxyguanosine triphosphate collectively activate an unusual RNA endonuclease activity of DRT4, excising 3′–guanosine monophosphate from both phage and host RNA to terminate infection. These findings reveal a distinctive immune strategy combining nucleic acid synthesis and degradation, expanding the functional landscape of DRTs for new DNA- and RNA-processing technologies.
- 22 April 2024
- Published by Springer Nature in Nature Microbiology
- Vol. 9 (6) , 1566-1578
Phage defence system CBASS is regulated by a prokaryotic E2 enzyme that imitates the ubiquitin pathway
The cyclic-oligonucleotide-based anti-phage signalling system (CBASS) is a type of innate prokaryotic immune system. Composed of a cyclic GMP–AMP synthase (cGAS) and CBASS-associated proteins, CBASS uses cyclic oligonucleotides to activate antiviral immunity. One major class of CBASS contains a homologue of eukaryotic ubiquitin-conjugating enzymes, which is either an E1–E2 fusion or a single E2. However, the functions of single E2s in CBASS remain elusive. Here, using biochemical, genetic, cryo-electron microscopy and mass spectrometry investigations, we discover that the E2 enzyme from Serratia marcescens regulates cGAS by imitating the ubiquitination cascade. This includes the processing of the cGAS C terminus, conjugation of cGAS to a cysteine residue, ligation of cGAS to a lysine residue, cleavage of the isopeptide bond and poly-cGASylation. The poly-cGASylation activates cGAS to produce cGAMP, which acts as an antiviral signal and leads to cell death. Thus, our findings reveal a unique regulatory role of E2 in CBASS.
- 22 April 2024
- Published by Springer Nature in Nature Microbiology
- Vol. 9 (6) , 1566-1578
Phage defence system CBASS is regulated by a prokaryotic E2 enzyme that imitates the ubiquitin pathway
The cyclic-oligonucleotide-based anti-phage signalling system (CBASS) is a type of innate prokaryotic immune system. Composed of a cyclic GMP–AMP synthase (cGAS) and CBASS-associated proteins, CBASS uses cyclic oligonucleotides to activate antiviral immunity. One major class of CBASS contains a homologue of eukaryotic ubiquitin-conjugating enzymes, which is either an E1–E2 fusion or a single E2. However, the functions of single E2s in CBASS remain elusive. Here, using biochemical, genetic, cryo-electron microscopy and mass spectrometry investigations, we discover that the E2 enzyme from Serratia marcescens regulates cGAS by imitating the ubiquitination cascade. This includes the processing of the cGAS C terminus, conjugation of cGAS to a cysteine residue, ligation of cGAS to a lysine residue, cleavage of the isopeptide bond and poly-cGASylation. The poly-cGASylation activates cGAS to produce cGAMP, which acts as an antiviral signal and leads to cell death. Thus, our findings reveal a unique regulatory role of E2 in CBASS.
- 12 March 2024
- Published by Springer Nature in Nature
- Vol. 629 (8011) , 467-473
Structures and activation mechanism of the Gabija anti-phage system
Prokaryotes have evolved intricate innate immune systems against phage infection1-7. Gabija is a highly abundant prokaryotic defense system consisting of two components, GajA and GajB8. We previously demonstrated that GajA functions as a DNA endonuclease that is inactive in the presence of ATP9. To reveal how the Gabija system is activated for anti-phage defense, we report its cryo-electron microscopy (cryo-EM) structures in five states, including apo GajA, GajA in complex with DNA, GajA bound by ATP, apo GajA-GajB, and GajA-GajB in complex with ATP/Mg2+. GajA is a rhombus-shaped tetramer with its ATPase domain clustered at the center and the Toprim domain located peripherally. ATP binding at the ATPase domain stabilizes the insertion region within the ATPase domain, keeping the Toprim domain in a closed state. Upon ATP depletion by phages, the Toprim domain opens to bind and cleave the DNA substrate. GajB, which docks on GajA, is activated by the cleaved DNA, ultimately leading to prokaryotic cell death. Our study presents a mechanistic landscape of Gajiba activation.
- 12 March 2024
- Published by Springer Nature in Nature
- Vol. 629 (8011) , 467-473
Structures and activation mechanism of the Gabija anti-phage system
Prokaryotes have evolved intricate innate immune systems against phage infection1-7. Gabija is a highly abundant prokaryotic defense system consisting of two components, GajA and GajB8. We previously demonstrated that GajA functions as a DNA endonuclease that is inactive in the presence of ATP9. To reveal how the Gabija system is activated for anti-phage defense, we report its cryo-electron microscopy (cryo-EM) structures in five states, including apo GajA, GajA in complex with DNA, GajA bound by ATP, apo GajA-GajB, and GajA-GajB in complex with ATP/Mg2+. GajA is a rhombus-shaped tetramer with its ATPase domain clustered at the center and the Toprim domain located peripherally. ATP binding at the ATPase domain stabilizes the insertion region within the ATPase domain, keeping the Toprim domain in a closed state. Upon ATP depletion by phages, the Toprim domain opens to bind and cleave the DNA substrate. GajB, which docks on GajA, is activated by the cleaved DNA, ultimately leading to prokaryotic cell death. Our study presents a mechanistic landscape of Gajiba activation.
- Open Access
- 10 January 2024
- Published by Springer Nature in Research Square
Structures and activation mechanism of Gabija anti-phage system
Bacteria have evolved intricate innate immune systems against phage infection1-7. Gabija is a highly abundant prokaryotic defense system in bacteria and archaea consisting of two components, GajA and GajB8. We previously demonstrated that GajA functions as a DNA endonuclease and is inhibited by ATP9. However, the mechanism of the anti-viral defense by Gabija is elusive. Here, we utilize cryo-EM to capture the Gabija system in five states, GajA in apo or complex with DNA, GajA inhibited by ATP, and GajAB in apo or with ATP/Mg2+. Our structures show that GajA is a rhombus-shaped tetramer that binds DNA in a bipartite manner. GajA recognizes and bends the substrate DNA to align the DNA cleavage site with the catalytic residues in the Toprim domain. DNA binding requires the opening of the hinged clamps, which are locked in a closed conformation upon ATP-binding, therefore inhibited by ATP. GajB does not bind DNA alone but docks on the GajA tetramer and is activated by the nicked DNA generated by GajA. Thus, GajA is activated by local depletion of cellular ATP, generating nicked DNA that activates GajB and ultimately leads to cell death. Our study unveiled a ~500 kDa supramolecular assembly of GajAB and provided mechanistic insights into the Gabija system.
- 10 January 2024
- Published by Springer Nature in Research Square
Open AccessStructures and activation mechanism of Gabija anti-phage system
Bacteria have evolved intricate innate immune systems against phage infection1-7. Gabija is a highly abundant prokaryotic defense system in bacteria and archaea consisting of two components, GajA and GajB8. We previously demonstrated that GajA functions as a DNA endonuclease and is inhibited by ATP9. However, the mechanism of the anti-viral defense by Gabija is elusive. Here, we utilize cryo-EM to capture the Gabija system in five states, GajA in apo or complex with DNA, GajA inhibited by ATP, and GajAB in apo or with ATP/Mg2+. Our structures show that GajA is a rhombus-shaped tetramer that binds DNA in a bipartite manner. GajA recognizes and bends the substrate DNA to align the DNA cleavage site with the catalytic residues in the Toprim domain. DNA binding requires the opening of the hinged clamps, which are locked in a closed conformation upon ATP-binding, therefore inhibited by ATP. GajB does not bind DNA alone but docks on the GajA tetramer and is activated by the nicked DNA generated by GajA. Thus, GajA is activated by local depletion of cellular ATP, generating nicked DNA that activates GajB and ultimately leads to cell death. Our study unveiled a ~500 kDa supramolecular assembly of GajAB and provided mechanistic insights into the Gabija system.
- 19 May 2011
- Published by Springer Nature in Frontiers of Law in China
- Vol. 6 (2) , 241-258
The ASEAN-China Investment Agreement: A regionalization of China’s BITs
- 19 May 2011
- Published by Springer Nature in Frontiers of Law in China
- Vol. 6 (2) , 241-258
The ASEAN-China Investment Agreement: A regionalization of China’s BITs